| • |
AngioDesign (Pty), Professor Edward D. Sturrock, IIDMM/UCT:
Structure-based design and synthesis of domain-selective Angiotensin Converting Enzyme Inhibitors for hypertension and cardiovascular disease |
| • |
World Health Organization (WHO) Tropical Disease Research (TDR), Geneva, Switzerland:
Hit to Lead medicinal chemistry for antimalarial and antileishmanial drug discovery |
| • |
Medicines for Malaria Venture (MMV), Geneva, Switzerland:
Hit to Lead medicinal chemistry for antimalarial drug discovery |
| • |
Radboud University Nijmegen, Netherlands, Professor Floris P. J. T Rutjes:
Synthetic Medicinal Chemistry of the antimalarial natural product Febrifugine |
| • |
African Institute of Biomedical Science and Technology (AiBST), Harare, Zimbabwe, Dr Collen Masimirembwa:
Integrating Drug Metabolism and Pharmacokinetic (DMPK) studies in drug discovery and Integrating African Natural Products and General Biodiversity Research into Modern Drug Discovery Paradigms |
| • |
University of Würzburg, Germany, Dr Gabi Pradel, Dr Marc Kirschner and Prof Axel Rethwilm:
Generation and characterization of candidates for malaria/HIV combination therapy |
| • |
Emory University, USA, Professor Lanny S. Liebeskind:
Development and application of enantiomeric organometallic scaffolding to anti-infective drug discovery |
